BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches.
Innovative Medicine Backed by the Power of AI
BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.
Innovative Medicine Backed by the Power of AI
BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.
Our Approach
to Drug
Development
Optimizes R&D Economics
Shortens Development Timelines
Increases Probability of Success
AI-based Drug Development
Our neuroscience and immuno-oncology franchises utilize our AI approach to drug identification and development